Evaxion A (EVAX) Current Assets (2019 - 2025)
Evaxion A (EVAX) reported Current Assets of $24.9 million for Q4 2025, up 184.1% on a YoY basis from $8.8 million in Q4 2024, and up 36.99% quarter-over-quarter from $18.2 million in Q2 2025.
Evaxion A (EVAX) Current Assets (2019 - 2025) Analysis & Trends
Evaxion A has reported Current Assets for 7 years, with the latest figure at $24.9 million in Q4 2025.
- For the quarter ending Q4 2025, Current Assets rose 184.1% year-over-year to $24.9 million; the trailing twelve-month figure through Dec 2025 stood at $24.9 million (up 184.1% YoY), and the FY2025 full-year result was $24.9 million, up 184.1% from the prior year.
- Current Assets for Q4 2025 stood at $24.9 million, up from $18.2 million in the prior quarter.
- The five-year high for Current Assets was $35.4 million in Q1 2022, with the low at $8.4 million in Q4 2023.
- Historically, Current Assets has averaged $20.8 million across 5 years, with a median of $18.2 million in 2025.
- Annual changes were most pronounced in 2021 — Current Assets jumped 216.94% — and 2023, when it sank 60.16%.
- Evaxion A's Current Assets stood at $34.7 million in 2021, then sank by 51.06% to $17.0 million in 2022, then tumbled by 50.84% to $8.4 million in 2023, then grew by 4.97% to $8.8 million in 2024, then soared by 184.1% to $24.9 million in 2025.
- The last three Current Assets figures came in at $24.9 million (Q4 2025), $18.2 million (Q2 2025), and $8.8 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 18.21 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.90 Mn |
| Jun 30, 2025 | 18.18 Mn |
| Dec 31, 2024 | 8.77 Mn |
| Jun 30, 2024 | 10.70 Mn |
| Dec 31, 2023 | 8.35 Mn |
| Jun 30, 2023 | 11.37 Mn |
| Dec 31, 2022 | 16.99 Mn |
| Jun 30, 2022 | 28.53 Mn |
| Mar 31, 2022 | 35.38 Mn |
| Dec 31, 2021 | 34.71 Mn |
| Sep 30, 2021 | 16.32 Mn |
| Jun 30, 2021 | 23.43 Mn |
| Mar 31, 2021 | 32.49 Mn |
| Dec 31, 2020 | 10.95 Mn |
| Dec 31, 2019 | 10.96 Mn |